Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

NeuroOne Medical Technologies Corporation - Common Stock (NQ:NMTC)

1.420 -0.040 (-2.74%)
Streaming Delayed Price Updated: 10:02 AM EDT, Sep 16, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 5,751
Open 1.430
Bid (Size) 1.420 (1,000)
Ask (Size) 1.450 (5,000)
Prev. Close 1.460
Today's Range 1.420 - 1.440
52wk Range 1.423 - 6.960
Shares Outstanding 12,000,585
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
BioMedNewsBreaks — NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) Completes Three Large-Animal Procedures Using StereoCED(TM) Platform
Via Investor Brand Network
News headline image
NeuroOne Announces Successful Robotic-Assisted Drug Delivery Using Next-Generation StereoCED(TM) Platform
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire

Performance

YTD
-72.2%
-72.2%
1 Month
-24.5%
-24.5%
3 Month
-56.3%
-56.3%
6 Month
-67.7%
-67.7%
1 Year
-73.1%
-73.1%

More News

Read More
News headline image
NeuroOne (NMTC) Q3 2026 Earnings Call Transcript ↗
Via The Motley Fool
Topics Earnings
News headline image
NeuroOne(R) Reports Fiscal Q3 2026 Financial Results, Revenues Increase 16% YoY to $2.0 Million; Gross Margins Expand to 59.9%
Via NewMediaWire
Topics Supply Chain
NeuroOne (NMTC) Q2 2026 Earnings Transcript ↗
Via The Motley Fool
NeuroOne Medical Technologies (NASDAQ:NMTC) Fiscal Q2 Revenue Surges 72% But Misses Estimates, Shares Dip ↗
Via Chartmill
News headline image
NeuroOne(R) Achieves Major Milestone With ISO 13485 Certification
Via NewMediaWire
News headline image
NeuroOne(R) to Report Third Quarter Fiscal Year 2026 Financial Results on Thursday, August 13, 2026, at 8:30 a.m. Eastern Time
Via NewMediaWire
Topics Earnings
News headline image
NeuroOne Releases CNS Drug Delivery White Paper Ahead of Planned Fiscal Year-End Availability of the StereoCED(TM) Platform
Via NewMediaWire
News headline image
NeuroOne(R) Highlights Potential Paradigm Shift for Patients Treated With the OneRF(R) Brain Ablation System Based on Reports by Physicians
Via NewMediaWire
News headline image
NeuroOne(R) Expands Drug Delivery Program Through Collaboration on Pediatric Brain Cancer Clinical Trial
Via NewMediaWire
News headline image
NeuroOne(R) Added to Russell Microcap(R) Index
Via NewMediaWire
NeuroOne(R) Added to Russell Microcap(R) Index
Via TheNewswire.com
News headline image
NeuroOne(R) Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Via NewMediaWire
NeuroOne(R) Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Via TheNewswire.com
NeuroOne(R) Announces Preliminary Inclusion in Russell Microcap(R) Index
Via TheNewswire.com
News headline image
NeuroOne(R) Announces Preliminary Inclusion in Russell Microcap(R) Index
Via NewMediaWire
NeuroOne(R) to Present at the Planet MicroCap Las Vegas 2026 Conference Wednesday, June 17, 2026 at 12:00 p.m. Pacific Time
Via TheNewswire.com
News headline image
NeuroOne(R) to Present at the Planet MicroCap Las Vegas 2026 Conference Wednesday, June 17, 2026 at 12:00 p.m. Pacific Time
Via NewMediaWire
News headline image
NeuroOne(R) to Present at the 2026 American Society for Stereotactic and Functional Neurosurgery Biennial Meeting on May 31, 2026
Via NewMediaWire
NeuroOne(R) to Present at the 2026 American Society for Stereotactic and Functional Neurosurgery Biennial Meeting on May 31, 2026
Via TheNewswire.com
News headline image
NeuroOne(R) Medical Technologies Announces Restatement of Financial Results for Quarter Ending March 31, 2026
Via NewMediaWire
NeuroOne(R) Medical Technologies Announces Restatement of Financial Results for Quarter Ending March 31, 2026
Via TheNewswire.com
News headline image
NeuroOne Reports Fiscal Q2 2026 Financial Results and Provides Corporate Business Update
Via NewMediaWire
Topics Economy
NeuroOne Reports Fiscal Q2 2026 Financial Results and Provides Corporate Business Update
Via TheNewswire.com
Topics Economy

Frequently Asked Questions

Is NeuroOne Medical Technologies Corporation - Common Stock publicly traded?
Yes, NeuroOne Medical Technologies Corporation - Common Stock is publicly traded.
What exchange does NeuroOne Medical Technologies Corporation - Common Stock trade on?
NeuroOne Medical Technologies Corporation - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for NeuroOne Medical Technologies Corporation - Common Stock?
The ticker symbol for NeuroOne Medical Technologies Corporation - Common Stock is NMTC on the Nasdaq Stock Market
What is the current price of NeuroOne Medical Technologies Corporation - Common Stock?
The current price of NeuroOne Medical Technologies Corporation - Common Stock is 1.420
When was NeuroOne Medical Technologies Corporation - Common Stock last traded?
The last trade of NeuroOne Medical Technologies Corporation - Common Stock was at 09/16/26 10:02 AM ET
What is the market capitalization of NeuroOne Medical Technologies Corporation - Common Stock?
The market capitalization of NeuroOne Medical Technologies Corporation - Common Stock is 17.04M
How many shares of NeuroOne Medical Technologies Corporation - Common Stock are outstanding?
NeuroOne Medical Technologies Corporation - Common Stock has 17M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.